Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):960-2. doi: 10.1016/j.pnpbp.2006.01.023. Epub 2006 Apr 24.

Abstract

Application of repetitive transcranial magnetic stimulation was effective and safe in treating a 55-year-old man with comorbid depression and panic disorder, which occurred 6 months after a myocardial infarction.

Publication types

  • Case Reports

MeSH terms

  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Citalopram / therapeutic use
  • Clorazepate Dipotassium / therapeutic use
  • Cyclohexanols / therapeutic use
  • Depressive Disorder / complications*
  • Depressive Disorder / etiology
  • Depressive Disorder / therapy*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / complications*
  • Myocardial Infarction / psychology*
  • Panic Disorder / complications*
  • Panic Disorder / etiology
  • Panic Disorder / therapy*
  • Psychiatric Status Rating Scales
  • Transcranial Magnetic Stimulation*
  • Venlafaxine Hydrochloride

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Citalopram
  • Clorazepate Dipotassium
  • Venlafaxine Hydrochloride